Progress in Mind
Your Psychiatry and Neurology online resource center
Choose a channel
Check out the different Progress in Mind content channels.
Parkinson's Disease
Congress highlights
EAN 2019: Research highlights in Parkinson’s disease
2019 is a bumper year for research, with over 850 abstracts on movement disorders presented at the...
Mental health
Article
Aiming for personalized treatment — detecting true-positive subgroups
The ultimate goal for personalized medicine is to prescribe the right treatment for the right...
Depression, Bipolar
Congress highlights
In search of biomarkers for mood disorders
Novel biomarkers for mood disorders will enable early diagnosis and inform the development of new...
Congress highlights
Plans to prioritize brain health
At a special joint EAN/EFNA session at EAN 2019, the state secretary of the Norwegian Ministry of...
Alzheimer's Disease
Congress highlights
Towards a novel understanding of Alzheimer’s disease
Genetic studies offer the best entry into understanding Alzheimer’s disease. This was the...
Congress highlights
A new framework to define essential tremor
Essential tremor is not a disease but a syndrome with many unknown etiologies, explained the...
Congress highlights
Insights into the neurobiology of functional movement disorders
At a joint MDS-European Section and EAN 2019 workshop session focusing on “Functional...
Mental health
Article
Patient-reported outcomes — need for more guidance and consistency
Patient-reported outcomes (PROs) are increasingly important for regulators. However, the European...
Depression
Congress highlights
Can inflammatory biomarkers help to personalize depression treatment?
Which treatment is best suited for which type of depression? Patients with a subtype of major...
Schizophrenia
Congress highlights
Early intervention for psychosis: Is it worth the investment?
In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,...
Bipolar
Satellite symposium
Maintaining functioning in bipolar disorder: Treat early and prevent relapses
Bipolar disorder (BD) should be considered a neuroprogressive disorder with poor outcomes1 said...
Depression
Satellite symposium
Treatment outcomes that matter – established and emerging therapies for patients with major depressive disorder who do not respond adequately to antidepressants
Major depressive disorder (MDD) has significant costs to society and is predicted to be the leading...
Featured articles
THINC®
Depression
Seminar
THINC® Online Course
Depression - 29.03.2016
Download
Download the THINC-it® Tool
Depression
Download
THINC-it® physician guide
The THINC-it® user guide is now available and can be downloaded here.
Depression
Interview
THINC-it® tool has now been validated! Its importance for measurement-based care in depression
Depression
Article
THINC-it® cognition screening tool now clinically validated
Depression
Article
Infographic for the health care provider describing THINC-it® as a simple, quick and effective way to screen for cognitive dysfunction in depression
Depression
Article
THINC-it® participant leaflet now available
Recommended videos
Video
Two sides of the same coin
7m:19s
Interview
Professor James MacCabe defines Treatment Resistance Schizophrenia
3m:27s
Video
Professor Mark Opler - Teaming up with patients
9m:09s
Video
Improvement in schizophrenia: Long and short term perspectives
5m:39s
Interview
John FP Bridges – Priorities of people living with SCZ
3m:39s
Video
Better understanding of depression, its symptoms and treatment, is needed
3m:39s
Interview
Control of side effects may be the key to solving the dopamine paradox of schizophrenia
3m:44s
Video
Expert insight: on residual and cognitive symptoms in MDD
Interview
John FP Bridges - Aiming for recovery: the world before Schizophrenia
4m:21s
Most popular on Progress in Mind
Depression, Schizophrenia
Article
ICD-11 – fielding for diagnostic success
In 2018, the World Health Organization (WHO) will release two important documents, both of which should aid for the better diagnosis of mental illness; the newer
Depression
Congress highlights
When to change first-line treatment: Debating an everyday dilemma
Schizophrenia
Congress highlights
Mapping of early intervention programs for psychosis in France
Schizophrenia
Congress highlights
Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?
Parkinson's Disease
Congress highlights
Getting rid of alpha-synuclein – active and passive immunotherapy, or maybe targeting LRRK2?
Alzheimer's Disease
Article
Advances in the early diagnosis of Alzheimer’s Disease
Article